BerGenBio Balance Sheet Health
Financial Health criteria checks 4/6
BerGenBio has a total shareholder equity of NOK127.5M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK174.3M and NOK46.9M respectively.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 156.42m |
| Equity | NOK 127.48m |
| Total liabilities | NOK 46.86m |
| Total assets | NOK 174.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BRRG.F's short term assets (NOK173.9M) exceed its short term liabilities (NOK46.9M).
Long Term Liabilities: BRRG.F has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BRRG.F is debt free.
Reducing Debt: BRRG.F had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BRRG.F has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BRRG.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 10.4% each year